Brainstorm Cell Therapeutics Inc Cash Flow-to-Debt Ratio
Brainstorm Cell Therapeutics Inc cash flow-to-debt ratio. Brainstorm Cell Therapeutics Inc (BCLI) has a Cash Flow-to-Debt Ratio of -0.07x as of June 2026, meaning its operating cash flow of $-895.00K could theoretically repay 0% of its total liabilities ($12.38 Million) in one year. Check Brainstorm Cell Therapeutics Inc earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Brainstorm Cell Therapeutics Inc (2001–2025)
Cash flow-to-debt ratio of Brainstorm Cell Therapeutics Inc from 2001 to 2025. Historical debt coverage capacity for Brainstorm Cell Therapeutics Inc across 25 annual periods. Check Brainstorm Cell Therapeutics Inc total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Brainstorm Cell Therapeutics Inc Cash Flow-to-Debt Ratio by Year (2001–2025)
Brainstorm Cell Therapeutics Inc cash flow-to-debt ratio by year from 2001 to 2025. Year-by-year debt coverage analysis for Brainstorm Cell Therapeutics Inc. For the full cash flow conversion analysis, see cash flow conversion of Brainstorm Cell Therapeutics Inc.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.63x | $-6.97 Million | $11.01 Million | ▲ +33.1% |
| 2024 | -0.95x | $-9.09 Million | $9.60 Million | ▲ +58.0% |
| 2023 | -2.26x | $-20.46 Million | $9.07 Million | ▼ -33.9% |
| 2022 | -1.68x | $-19.32 Million | $11.47 Million | ▲ +36.3% |
| 2021 | -2.64x | $-26.27 Million | $9.94 Million | ▼ -18.7% |
| 2020 | -2.23x | $-35.19 Million | $15.79 Million | ▼ -271.6% |
| 2019 | -0.60x | $-11.25 Million | $18.76 Million | ▲ +69.9% |
| 2018 | -1.99x | $-12.39 Million | $6.21 Million | ▼ -367.6% |
| 2017 | -0.43x | $-2.36 Million | $5.54 Million | ▲ +93.7% |
| 2016 | -6.78x | $-5.86 Million | $864.00K | ▼ -170.2% |
| 2015 | -2.51x | $-7.41 Million | $2.95 Million | ▼ -81.0% |
| 2014 | -1.39x | $-4.49 Million | $3.24 Million | ▲ +32.0% |
| 2013 | -2.04x | $-4.05 Million | $1.99 Million | ▲ +19.1% |
| 2012 | -2.52x | $-2.92 Million | $1.16 Million | ▼ -42.5% |
| 2011 | -1.77x | $-2.22 Million | $1.26 Million | ▼ -32.4% |
| 2010 | -1.34x | $-2.07 Million | $1.55 Million | ▼ -349.1% |
| 2009 | -0.30x | $-744.00K | $2.50 Million | ▲ +49.4% |
| 2008 | -0.59x | $-1.73 Million | $2.95 Million | ▼ -16.3% |
| 2007 | -0.51x | $-1.77 Million | $3.51 Million | ▼ -50.0% |
| 2006 | -0.34x | $-855.00K | $2.54 Million | ▼ -135.9% |
| 2005 | -0.14x | $-1.25 Million | $8.77 Million | ▲ +96.3% |
| 2004 | -3.87x | $-677.84K | $174.95K | ▼ -1096.4% |
| 2003 | -0.32x | $-15.44K | $47.67K | ▼ -16.0% |
| 2002 | -0.28x | $-7.01K | $25.13K | ▲ +56.9% |
| 2001 | -0.65x | $-7.44K | $11.49K | — |